Priority Research Centre for Healthy Lungs, University of Newcastle and Hunter Medical Research Institute, Newcastle, New South Wales 2305, Australia.
Australian Centre for Ecogenomics, School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Queensland 4072, Australia.
Nat Rev Microbiol. 2017 Jan;15(1):55-63. doi: 10.1038/nrmicro.2016.142. Epub 2016 Oct 3.
The microbiota is vital for the development of the immune system and homeostasis. Changes in microbial composition and function, termed dysbiosis, in the respiratory tract and the gut have recently been linked to alterations in immune responses and to disease development in the lungs. In this Opinion article, we review the microbial species that are usually found in healthy gastrointestinal and respiratory tracts, their dysbiosis in disease and interactions with the gut-lung axis. Although the gut-lung axis is only beginning to be understood, emerging evidence indicates that there is potential for manipulation of the gut microbiota in the treatment of lung diseases.
肠道微生物对于免疫系统和体内平衡的发育至关重要。最近,呼吸道和肠道中微生物组成和功能的改变(称为微生态失调)与免疫反应的改变以及肺部疾病的发展有关。在这篇观点文章中,我们综述了通常存在于健康胃肠道和呼吸道中的微生物种类、它们在疾病中的失调以及与肠-肺轴的相互作用。尽管肠-肺轴才刚刚开始被理解,但新出现的证据表明,有可能通过操纵肠道微生物群来治疗肺部疾病。